The Journal of Urology
Volume 182, Issue 1 , Pages 35-40 , July 2009

The Prognostic Impact of Comorbidities on Renal Cancer, 1995 to 2006: A Danish Population Based Study

  • Lars Lund

      Affiliations

    • Department of Urology, Viborg Hospital, Viborg, Denmark
    • Vanderbilt University Medical Center, Nashville, Tennessee
    • Corresponding Author InformationCorrespondence: Department of Urology, Viborg Hospital, Heibergs alle, 8800 Viborg, Denmark (telephone: (+45) 89272345; FAX: (+45) 89273481)
    • ,
  • Jacob Jacobsen

      Affiliations

    • Department of Clinical Epidemiology, Aarhus University Hospital, Skejby, Denmark
    • ,
  • Mette Nørgaard

      Affiliations

    • Department of Clinical Epidemiology, Aarhus University Hospital, Skejby, Denmark
    • ,
  • Joseph K. McLaughlin

      Affiliations

    • Vanderbilt University Medical Center, Nashville, Tennessee
    • International Epidemiology Institute, Rockville, Maryland
    • ,
  • William J. Blot

      Affiliations

    • Vanderbilt University Medical Center, Nashville, Tennessee
    • International Epidemiology Institute, Rockville, Maryland
    • ,
  • Michael Borre

      Affiliations

    • Department of Urology, Aarhus University Hospital, Skejby, Denmark
    • ,
  • Henrik T. Sørensen

      Affiliations

    • Department of Clinical Epidemiology, Aarhus University Hospital, Skejby, Denmark
    • Vanderbilt University Medical Center, Nashville, Tennessee
    • Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts

Received 8 December 2008

References 

  1. In: Cancer Incidence in Denmark. Copenhagen: National Board of Health Copenhagen; 2000;p. 204
  2. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer incidence in five countries. IARC Sci. 1992;120:978
  3. Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628
  4. Konnak J, Grossman H. Renal cell carcinoma as an incidental finding. J Urol. 1985;134:1094
  5. McLaughlin JK, Lindblad P, Mellemgaard A, McCredie M, Mandel JS, Schlehofer B, et al. International renal-cell cancer study (I. Tobacco use). Int J Cancer. 1995;60:194
  6. Mellemgaard A, Lindblad P, Schlehofer B, Bergström R, Mandel JS, McCredie M, et al. International renal-cell cancer study (III. Role of weight, height, physical activity, and the use of amphetamines). Int J Cancer. 1995;60:350
  7. McLaughlin JK, Chow WH, Mandel JS, Mellemgaard A, McCredie M, Lindblad P, et al. International renal-cell cancer study (VII. Role of diuretics, other antihypertensive medications and hypertension). Int J Cancer. 1995;60:216
  8. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity (a critical review of available methods). J Clin Epidemiol. 2003;56:221
  9. Gettman M, Boelter CW, Cheville JC, Zincke H, Bryant SC, Blute ML. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol. 2003;169:1282
  10. Santos Arrontes D, FernándezAceñero MJ, GarcíaGonzález JI, MartínMuñoz M, PaniaguaAndrés P. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index. J Urol. 2008;179:857
  11. Berger DA, Megwalu II, Vlahiotis A, Radwan MH, Serrano MF, Humphrey PA, et al. Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma. Urology. 2008;72:359
  12. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register (A valuable source of data for modern health sciences). Dan Med Bull. 1999;46:263
  13. Tetsche MS, Nørgaard M, Skriver MV, Andersen ES, Lash TL, Sørensen HT. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based Hospital discharge registry. Eur J Gyn Oncol. 2005;26:266
  14. Frank L. Epidemiology (When an entire country is a cohort). Science. 2000;287:2398
  15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373
  16. Rothman KJ. Epidemiology: An Introduction. 2nd ed.. Oxford: Oxford University Press; 2002;
  17. Gaist D, Sørensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44:445
  18. Sorensen HT. Regional administrative health registers as a resource in clinical epidemiology (A study of options, strengths, limitations and data quality provided with examples of use). Int J Risk Safety Med. 1997;10:1
  19. Bo M, Cacello E, Ghiggia F, Corsinovi L, Bosco F. Predictive factors of clinical outcome in older surgical patients. Arch Gerontol Geriatr. 2006;44:215
  20. Corman JM, Penson DF, Hur K, Khuri SF, Daley J, Henderson W, et al. Comparison of complications after radical and partial nephrectomy: results from the national Veterans Administration surgical quality improvement program. BJU Int. 2000;86:782
  21. Dunn MD, Portes AJ, Shalhav AL. Laparoscopic versus open nephrectomy: a 9-year experience. J Urol. 2000;164:1153
  22. Naya Y, Tobe T, Suyama T, Araki K, Komiya A, Suzuki H, et al. The efficacy and safety of laparoscopic nephrectomy in patients with three or more comorbidities. Int J Urol. 2007;14:17

 Study received approval from the Danish Data Protection Agency and Aarhus University Registry Board.

 Supported by the Almennyttige Fond, Jyske Bank, Denmark and the Karen Elise Jensen Fond.

PII: S0022-5347(09)00572-2

doi: 10.1016/j.juro.2009.02.136

The Journal of Urology
Volume 182, Issue 1 , Pages 35-40 , July 2009

Article Tools

* Image Usage & Resolution